Recommender-based bone tumour classification with radiographs—a link to the past

• by Florian Hinterwimmer, Ricardo Smits Serena, Nikolas Wilhelm, Sebastian Breden, Sarah Consalvo, Fritz Seidl, Dominik Juestel, Rainer H. H. Burgkart, Klaus Woertler, Ruediger von Eisenhart-Rothe, Jan Neumann, Daniel Rueckert

• March 15, 2024

Advances in Hodgkin Lymphoma Treatment: Clinical Considerations for Managing Toxicities in Nivolumab-AVD Therapy

One of the most promising developments in advanced-stage Hodgkin lymphoma is the nivolumab-AVD regimen, which combines nivolumab with doxorubicin, vinblastine, and dacarbazine. This article provides practical knowledge for advanced practitioners to effectively manage the most common toxicities associated with nivolumab-AVD.

• by Maria D. Guerrero

• May 6, 2026

• 13 min

Treatment Intensity in the Frontline Setting for Transplant-Ineligible Patients With Multiple Myeloma

The management of newly diagnosed transplant-ineligible multiple myeloma remains challenging, in part due to the complexity of treatment decisions for frail patients. Recent subgroup analyses provide insight into whether quadruplet therapy may offer advantages over triplet therapy in this population.

• by Mark Davis

• May 6, 2026

• 18 min

The Impact of Physical Activity Levels on Sexual Function in Breast Cancer Survivors: An Integrative Review

Sexual dysfunction is a lasting effect of treatment and can impact the quality of life of breast cancer survivors. This review examined the impact of different levels (none/low, moderate, and high) of physical activity on sexual outcomes in breast cancer survivors.

• by Mary Sou, Ashley Martinez, Joyce Dains

• May 13, 2026

• 25 min